ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,836.00
      1.31%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.72
      0.00%
      Bitcoin
      96,940.84
      -0.27%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. Solventum Corporation (SOLV) Quote

      Solventum Corporation

      Solventum Corporation (SOLV)

      SolVBL Solutions Inc
      Solvac SA
      66.83
      0.03
      (0.04%)
      Closed December 21 4:00PM
      Delayed by 15 minutes
      66.83
      0.00
      (0.00%)
      After Hours: 7:09PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      66.83
      Bid
      -
      Ask
      -
      Volume
      1,798,749
      66.2846 Day's Range 67.50
      47.16 52 Week Range 76.4306
      Market Cap
      11.545B
      Previous Close
      66.80
      Open
      66.58
      Last Trade
      609877
      @
      66.83
      Last Trade Time
      Financial Volume
      $ 120,294,259
      VWAP
      66.8766
      Average Volume (3m)
      942,415
      Shares Outstanding
      172,754,070
      Dividend Yield
      -
      PE Ratio
      16.68
      Earnings Per Share (EPS)
      4.01
      Revenue
      8.24B
      Net Profit
      692M

      About Solventum Corporation

      Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symboliz... Solventum originates from two words: 'solving' and 'momentum.'Solving' captures the company's dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. 'Momentum' symbolizes swifter, nimbler innovation. As the independent health care company builds on every achievement, large and small, its momentum propels it past barriers, towards breakthroughs. The new name represents how the independent health care company will focus on solving big health care challenges and emphasizes the tremendous impact it can make on the world. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.solventum.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Solventum Corporation is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker SOLV. The last closing price for Solventum was $66.80. Over the last year, Solventum shares have traded in a share price range of $ 47.16 to $ 76.4306.

      Solventum currently has 172,754,070 shares outstanding. The market capitalization of Solventum is $11.54 billion. Solventum has a price to earnings ratio (PE ratio) of 16.68.

      Ask ADVFN Intelligence (AI)

      SOLV Latest News

      More News

      Form EFFECT - Notice of Effectiveness

      December 18 2024
      Edgar (US Regulatory)

      Form POS AM - Post-Effective amendments for registration statement

      December 11 2024
      Edgar (US Regulatory)

      Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

      December 10 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 03 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 03 2024
      Edgar (US Regulatory)

      Form EFFECT - Notice of Effectiveness

      December 03 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      December 02 2024
      Edgar (US Regulatory)

      Solventum to Participate in the Piper Sandler Healthcare Conference

      Solventum to Participate in the Piper Sandler Healthcare Conference PR Newswire ST. PAUL, Minn., Nov. 19, 2024 ST. PAUL, Minn., Nov. 19, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) announced...

      November 19 2024
      PR Newswire (US)

      Form S-4 - Registration of securities, business combinations

      November 15 2024
      Edgar (US Regulatory)

      Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment

      Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment PR Newswire ST. PAUL, Minn., Nov. 14, 2024 Clarity Precision Grip Attachments are fully cured...

      November 14 2024
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-2.55-3.675410781269.3870.3466.2176774168.09482038CS
      4-3.43-4.8818673498470.2672.80566.2182158770.16312024CS
      12-1.58-2.3096038590868.4176.430665.9594241570.44607126CS
      2613.8926.237249716752.9476.430647.16124786962.46256314CS
      52-2.32-3.355025307369.1576.430647.16160659662.83192552CS
      156-2.32-3.355025307369.1576.430647.16160659662.83192552CS
      260-2.32-3.355025307369.1576.430647.16160659662.83192552CS

      SOLV - Frequently Asked Questions (FAQ)

      What is the current Solventum share price?
      The current share price of Solventum is $ 66.83
      How many Solventum shares are in issue?
      Solventum has 172,754,070 shares in issue
      What is the market cap of Solventum?
      The market capitalisation of Solventum is USD 11.54B
      What is the 1 year trading range for Solventum share price?
      Solventum has traded in the range of $ 47.16 to $ 76.4306 during the past year
      What is the PE ratio of Solventum?
      The price to earnings ratio of Solventum is 16.68
      What is the cash to sales ratio of Solventum?
      The cash to sales ratio of Solventum is 1.4
      What is the reporting currency for Solventum?
      Solventum reports financial results in USD
      What is the latest annual turnover for Solventum?
      The latest annual turnover of Solventum is USD 8.24B
      What is the latest annual profit for Solventum?
      The latest annual profit of Solventum is USD 692M
      What is the registered address of Solventum?
      The registered address for Solventum is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Solventum website address?
      The website address for Solventum is www.solventum.com
      Which industry sector does Solventum operate in?
      Solventum operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      VNCEVince Holding Corp
      $ 4.70
      (69.06%)
      		1.06M
      SRFMSurf Air Mobility Inc
      $ 3.33
      (23.79%)
      		367.21k
      BBBlackBerry Limited
      $ 3.685
      (23.66%)
      		40.27M
      ALURAllurion Technologies Inc
      $ 0.3439
      (22.87%)
      		702.83k
      CLWClearWater Paper Corporation
      $ 30.26
      (22.46%)
      		3.5M
      IIPRInnovative Industrial Properties Inc
      $ 73.50
      (-22.91%)
      		3.15M
      KUKEKuke Music Holding Limited
      $ 0.31
      (-20.51%)
      		61.21k
      NVONovo Nordisk
      $ 85.00
      (-17.83%)
      		53.78M
      CANGCango Inc
      $ 5.08
      (-11.81%)
      		2.27M
      BNEDBarnes and Noble Education Inc
      $ 9.965
      (-10.31%)
      		1.52M
      QBTSD Wave Quantum Inc
      $ 6.638
      (4.21%)
      		124.23M
      PFEPfizer Inc
      $ 26.36
      (2.29%)
      		111.08M
      APOApollo Global Management Inc
      $ 171.03
      (0.83%)
      		94.47M
      TAT&T Inc
      $ 22.75
      (0.80%)
      		88.77M
      FFord Motor Company
      $ 9.885
      (1.49%)
      		87.61M

      SOLV Discussion

      View Posts
      DewDiligence DewDiligence 1 month ago
      SOLV 3Q24 Results by Business Segment
      %Corp YoY Growth
      Segment Sales Organic Sales†
      Medical/surgical* 57% +1%
      Dental 15% -4%
      Health-info systems 16% +2%
      Purification/filtration 11% 0% †Excludes acquisitions, divestitures, and currency.

      *Includes components for other companies’ medical devices.
      👍️0
      DewDiligence DewDiligence 1 month ago
      SOLV reports 3Q24 results—raises 2024 guidance…

      New 2024 guidance is as follows:

      • Non-GAAP EPS of $6.50-6.65 (vs prior guidance of $6.30-6.50).

      • Organic sales growth of 0.5-1.0% (vs prior guidance of 0-1%).

      • FCF of $750-850M (vs prior guidance of $700-800M).

      At the current share price (~$77 as I’m typing), the midpoint of the new 2024 non-GAAP EPS guidance range represents a P/E ratio of 11.7x.


      PR:
      https://investors.solventum.com/image/2024-11-07-Solventum-Reports-Third-Quarter-2024-Financial-Results-and-Raises-Full-Year-Guidance.pdf

      CC slides:
      https://investors.solventum.com/image/SOLV+Q3+2024+Earnings+Presentation.pdf
      👍️0
      DewDiligence DewDiligence 2 months ago
      SOLV seeking buyer for filtration business, according to WSJ sources:

      https://www.wsj.com/business/deals/recent-3m-spinoff-explores-sale-of-filtration-unit-f331a83d

      In 2Q24, the filtration segment comprised 12% of SOLV’s sales, but the growth rate was non-existent (#msg-174889792).
      👍️0
      DewDiligence DewDiligence 2 months ago
      SOLV hires CMO:

      https://finance.yahoo.com/news/solventum-names-surgeon-diagnostics-pioneer-130000072.html
      👍️0
      DewDiligence DewDiligence 4 months ago
      SOLV 2Q24 CC slides:

      https://investors.solventum.com/image/Q2+2024+Earnings+Presentation+-+FINAL+8.8.24.pdf
      👍️0
      DewDiligence DewDiligence 4 months ago
      SOLV 2Q24 Results by Business Segment
      %Corp YoY Growth
      Segment Sales Organic Sales†
      Medical/surgical* 56% +2%
      Dental 16% -2%
      Health-info systems 16% +4%
      Purification/filtration 12% -1% †Excludes acquisitions, divestitures, and currency.

      *Includes components for other companies’ medical devices.
      👍️0
      DewDiligence DewDiligence 4 months ago
      SOLV’s raised 2024 guidance is as follows:

      https://finance.yahoo.com/news/solventum-reports-second-quarter-2024-200500242.html

      • 2024 organic sales growth of 0-1% (up from the prior range of -2% to 0%).

      • 2024 non-GAAP EPS of $6.30-6.50 (up from the prior range of $6.10-6.40).

      At the current share price ($60.00 as I’m typing), the midpoint of the new 2024 non-GAAP EPS guidance range represents a P/E ratio of 9.4x.
      👍️0
      abrooklyn abrooklyn 4 months ago
      Solventum Reports Second Quarter 2024 Financial Results and Raises Full-Year Guidance

      Source: PR Newswire (US)
      Separation activities and business continuity on track
      Reported sales increased 0.2% to $2.081 billion; organic sales increased 1.3%
      GAAP Earnings Per Share (EPS) of $0.51; adjusted EPS1 of $1.56
      Generated $355 million in cash from operations; free cash flow1 of $297 million
      Raises full-year 2024 organic sales growth and adjusted EPS guidance
      ST. PAUL, Minn., Aug. 8, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results as a stand-alone company for the second quarter ended June 30, 2024.

      Solventum Logo (PRNewsfoto/3M Healthcare US Opco LLC)

      "As we continue to execute a complex transformation, we're encouraged by our first financial results as an independent company and early ability to maintain business continuity," said?Bryan Hanson, chief executive officer, Solventum. "We are starting from a solid foundation and remain focused on addressing historical underperformance and spin-related topics to unlock significant value creation over time."
      👍️ 1
      DewDiligence DewDiligence 5 months ago
      Activist_investor_builds_stake_in SOLV—(3M’s healthcare spinoff):

      https://finance.yahoo.com/news/peltz-trian-building-stake-3m-230900848.html
      👍️0
      DewDiligence DewDiligence 6 months ago
      SOLV 1Q24 Results by Business Segment
      %Corp YoY Growth
      Segment Sales (const currency)
      Medical/surgical* 56% flat
      Dental 17% flat
      Health-info systems 16% flat
      Purification/filtration 12% +7% *Includes components for other companies’ medical devices.
      👍️0
      DewDiligence DewDiligence 6 months ago
      SOLV’s “AI play”—>heath-information systems segment:

      https://finance.yahoo.com/news/solventum-introduces-denials-prevention-solution-130000721.html

      Heath-information systems comprised 16% of SOLV’s overall (pro forma) sales in 1Q24 (#msg-174387294), but SOLV expects this figure to steadily increase due to the application of AI.
      👍️0
      KingOfSwing...Trading KingOfSwing...Trading 7 months ago
      Thank for the excellent post. Very useful.
      👍️0
      DewDiligence DewDiligence 7 months ago
      SOLV reports pro forma 1Q24 results—reiterates 2024 guidance:

      https://finance.yahoo.com/news/solventum-reports-first-quarter-2024-105000516.html

      SOLV was spun out of 3M on 4/1/24, so the 1Q24 financial results are pro forma based on what SOLV would have reported if it had it been an independent company.

      SOLV re-iterated 2024 guidance given on 3/19/24—see #msg-174067513. (2024 guidance includes the pro forma financials for 1Q24 and actual SOLV results for the remainder of the year.)

      The only consequential update is that SOLV is not initiating a dividend, so that free cash flow can be directed toward paying down debt. This decision is not surprising in light of the large debt load SOLV took on as part of the spinoff from 3M.

      p.s. No 1Q24 CC due to the Investor Day webcast just a few weeks ago.
      👍️0
      Porgie Tirebiter Porgie Tirebiter 9 months ago
      All of a sudden, I own shares of SOLV! I guess I should have been paying more attention to 3M.

      I've had 3M for years and years, just collecting the dividend and probably not paying enough attention to it!
      👍️0
      DewDiligence DewDiligence 9 months ago
      SOLV begins trading on NYSE following completion of spinoff from 3M:

      https://finance.yahoo.com/news/solventum-begins-trading-york-stock-103000676.html
      👍️ 1
      DewDiligence DewDiligence 9 months ago
      SOLV Investor Day CC slides:

      https://d1io3yog0oux5.cloudfront.net/_7984eceea22d0dd69e55aae6e648ee7c/3m/db/3194/30840/presentation/Solventum+Investor+Day+3.19.2024.pdf
      👍️ 1
      DewDiligence DewDiligence 9 months ago
      SOLV issues 2024 guidance:

      https://finance.yahoo.com/news/solventum-hosts-inaugural-investor-day-103000871.html

      • Organic revenue growth of -2% to 0%

      • Adjusted earnings per share (EPS) of $6.10 to $6.40

      • Free cash flow of $700M to $800M
      👍️ 1
      DewDiligence DewDiligence 9 months ago
      Details of 3M’s SOLV spinoff finalized:

      https://finance.yahoo.com/news/3m-board-directors-approves-spin-165500127.html

      3M shareholders of record on 3/18/24 will receive 1 share of SOLV for every 4 shares of 3M. The SOLV shares will be distributed before the market open on 4/1/24.

      This is a tax-exempt distribution for US residents.
      👍️0
      DewDiligence DewDiligence 10 months ago
      SOLV sells $6.9B of debt in six tranches:

      • $1B of 3yr notes @5.45%

      • $1.5B of 5yr notes @5.40%

      • $1B of 7yr notes @5.45%

      • $1.65B of 10yr notes @5.60%

      • $1.25B of 30yr notes @5.90%

      • $0.5B of 40yr notes @6.00%

      The total debt issuance was supposed to $8.4B (according to 3M's recent webcast), but I don't know where the other $1.5B is coming from.

      All but $600M of the proceeds will be paid to 3M as consideration for the spin-off of 3M’s healthcare business to SOLV.
      👍️ 1
      DewDiligence DewDiligence 10 months ago
      SOLV is holding an Investor Day webcast 3/19/24 at 9am ET.
      👍️0
      DewDiligence DewDiligence 10 months ago
      These are the five focal areas for 3M’s healthcare business that will become part of Solventum; they comprise about 25% of 3M’s current company-wide sales:

      https://engage.3m.com/purification

      https://www.3m.com/3M/en_US/health-information-systems-us/

      https://www.3m.com/3M/en_US/medical-us/ (surgical supplies and wound care)

      https://www.3m.com/3M/en_US/medical-device-components-us/ (components for other companies’ medical devices)

      https://www.3m.com/3M/en_US/oral-care-us/ (dentistry and othodontics)
      👍️0
      DewDiligence DewDiligence 10 months ago
      Further details of 3M/SOLV capitalization:

      SOLV will sell $8.4B of new debt, keeping $600M of the proceeds and paying $7.7B as a one-time (tax-free) dividend to 3M. (~$100M of the debt proceeds will go to underwriting fees.)

      After the debt issuance and one-time payment to 3M, SOLV will have a debt/EBITDA ratio of ~3.5.
      👍️0
      DewDiligence DewDiligence 10 months ago
      3M sets 4/1/24 date for Solventum spin-off:

      https://d1io3yog0oux5.cloudfront.net/_28c5051c41e86ce7771a2dfe11a5ee94/3m/news/2024-02-21_3M_Announces_Filing_of_Form_10_Registration_1826.pdf
      👍️0

      Your Recent History

      NYSE
      SOLV
      Solventum
      COIN
      SOPUSD
      SoPay
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads